Account Information

  • My Account

    Manage all your subscriptions, update your address, email preferences and change your password.

  • Help Center

    Get answers to common service questions, ask the analyst or contact our customer service department.

  • My Stock Talk Profile

    Update your stock talk name and/or picture.


Are you prepared for what the market is going to do next?

Boring, Predictable, No-Surprises Strategy Safely Generates $67,548An economist who’s predicted nearly every major economic turn over the past 30 years… including the Dow’s rise past 14,000 points, the 2001 tech crash, and the 2008 housing crash… just made his boldest prediction to date. You’ll be surprised when you hear what he’s forecast for the next 2 years. You must act now… the dominoes have already started falling. Click here for the details.


Healthcare ETF Turns Gray Into Green

By Benjamin Shepherd on August 9, 2012

While many might fib about their age, the world’s population is getting older. Between 1950 and 2000, the median age of the glob­al population rose from 23.6 years to 26.4 years. And by 2050, it’s ex­pected to reach 37 years. Around that same time, 19 developed countries will reach median ages greater than 50 years. 

As the world gets steadily grayer, developing countries are already struggling to cope with lifestyle diseases. An improving standard of living in the emerging markets has paradoxically spurred higher rates of obesity, diabetes and can­cer. The increasing prevalence of such diseases is, in turn, driving demand for health care. Recent data show that China now has about 90 million diabetics, which means the Middle Kingdom is home to the largest population of diabetics in the world. And India comes in second, with almost 62 million diabetes sufferers. By comparison, the US has an estimated 25.8 million diabetics.

The resulting demand for health care means spending in this sector is expected to outpace economic growth in both the de­veloped and emerging markets. A study conducted by PriceWa­terhouseCoopers estimated that while gross domestic product (GDP) is expected to grow 38 per­cent in the U.S. and 115 percent in China over the course of this de­cade, health care spending is ex­pected to jump 57 percent and 167 percent, respectively.

In the emerging markets, de­mand growth is largely due to the underpenetration of health care services. Meanwhile, the US has significant catalysts for greater spending, including health care reform, the pending wave of baby boomer retirees, and the ongoing economic recovery.

Over the past several years, growth in health care spending has slowed significantly, largely thanks to high unemployment in the wake of the Great Recession. But health care spending should soon ramp up as more Americans return to work and once again have access to benefits through their employers. And assum­ing President Obama’s landmark health care reform survives the next Congress, its massive expan­sion of coverage will provide a fur­ther boost.

That’s made iShares S&P Glob­al Healthcare Sector Index Fund (NYSE: IXJ) an increasingly attrac­tive proposition. The exchange-traded fund (ETF) covers the full breadth of the health care indus­try, with exposure to biotech firms, pharmaceuticals, medical devices and insurers.

Despite the fact that its 92 com­ponent holdings are all based in the developed world—top posi­tions include names such as John­son & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE) and Novartis (NYSE: NVS)—a surprisingly large percentage of the total revenues gen­erated by the names in the ETF’s portfolio are derived from emerg­ing economies.

For example, almost 15 percent of Pfizer’s revenues are sourced from emerging markets, and sales growth in those geographies is running about 8 percent annually. Based on the most recently avail­able quarterly reports from the fund’s largest holdings, about 25 percent of total revenues are pro­duced in the emerging markets.

The tax-efficient ETF has an an­nual turnover ratio of just 6 per­cent. Additionally, the fund has a 0.48 percent annual expense ratio, which makes it an affordable play on the inexorable rise in global health care demand.

What do you think of this article? Please post your feedback in the “comments” section below!

You might also enjoy…


Forget Buy and Hold. Here’s how to retire faster…

I’m not a fan of “buy and hold.” Gurus like to tell you that patience is the key, but I call horse puckey.

We’ve discovered an investing technique that consistently pays out easy-to-repeat profits.

One that’s proven to beat the market 2,082% in head-to-head testing.

And one that’s generated over 488 winners since 2011.

This method is so powerful, in fact, some of the investors we’ve let use it reported back to us saying they’ve made $71,425… $82,371… and even as much as $151,000 in a single year thanks to this “trick.”

That’s how powerful this investing technique is!

What what exactly is this mysterious method? I’ve put all the details together here.

Stock Talk — Post a comment Comment Guidelines

Our Stock Talk section is reserved for productive dialogue pertaining to the content and portfolio recommendations of this service. We reserve the right to remove any comments we feel do not benefit other readers. If you have a general investment comment not related to this article, please post to our Stock Talk page. If you have a personal question about your subscription or need technical help, please contact our customer service team. And if you have any success stories to share with our analysts, they’re always happy to hear them. Note that we may use your kind words in our promotional materials. Thank you.

You must be logged in to post to Stock Talk OR create an account.

Create a new Investing Daily account

  • - OR -

* Investing Daily will use any information you provide in a manner consistent with our Privacy Policy. Your email address is used for account verification and will remain private.